Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAbzena Regulatory News (ABZA)

  • There is currently no data for ABZA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director Dealings

22 Dec 2014 16:57

RNS Number : 5171A
Abzena PLC
22 December 2014
 



ABZENA PLC

 

("Abzena", the "Company" or the "Group")

 

Director Dealings

 

 

22 December 2014

 

Cambridge, UK - Abzena plc (AIM: ABZA) was today notified by John Burt (Chief Executive Officer) that he has transferred ordinary shares in Abzena into his personal pension.

 

John Burt has transferred 145,000 ordinary shares in Abzena at a price of 77.8 pence per share into his personal pension. This transaction has no effect on John Burt's beneficial ownership; he continues to hold a total direct and indirect voting right interest in 1,695,725 ordinary shares in Abzena, being approximately 1.740% of the issued ordinary share capital of Abzena of 97,428,858 ordinary shares of £0.002.

 

For more information, please contact:

 

John Burt (Chief Executive Officer)

Julian Smith (Chief Financial Officer)

Abzena plc

Tel: +44 (0)1223 903498

Email: john.burt@abzena.com or julian.smith@abzena.com

 

Christopher Golden and Bobbie Hilliam

Cenkos Securities (Nominated Adviser and Broker)

Tel: +44 (0)20 7397 8900

 

Mark Swallow, Sita Taylor or Chris Gardner

Citigate Dewe Rogerson (Corporate and Financial PR)

Tel: +44 (0)20 7638 9571

Email: abzena@citigatedr.co.uk

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSKMMZZVZKGDZM
Date   Source Headline
11th Jan 20162:14 pmRNSHolding(s) in Company
6th Jan 20161:57 pmRNSLicensed product candidate update
5th Jan 20163:18 pmRNSBlocklisting Interim Review
18th Dec 20152:21 pmRNSHolding(s) in Company
15th Dec 201511:42 amRNSHolding(s) in Company
11th Dec 20154:12 pmRNSHolding(s) in Company
11th Dec 20153:13 pmRNSCompletion of Acquisition
10th Dec 201512:15 pmRNSResult of General Meeting
24th Nov 20157:00 amRNSPlacing to raise £20 million and acquisition
24th Nov 20157:00 amRNSHalf year results
21st Oct 20159:52 amRNSAppointment of joint broker
9th Oct 201512:34 pmRNSAdheron Therapeutics acquired by Roche
22nd Sep 201510:00 amRNSAGM Results
21st Sep 20157:00 amRNSPre-AGM Business Update
14th Sep 20157:00 amRNSAcquisition of PacificGMP
27th Aug 20153:37 pmRNSNotice of AGM
7th Aug 20157:00 amRNSExercise of Employee Share Options
7th Jul 20153:20 pmRNSBlock Admission
15th Jun 20151:03 pmRNSAnnual Financial Report
8th Jun 20157:00 amRNSResults for the year ended 31 March 2015
1st Jun 20157:00 amRNSNotice of Results
19th May 20157:00 amRNSCollaboration
13th May 20158:00 amRNSLicensed product candidate update
9th Apr 20157:00 amRNSProduct Development Update
2nd Apr 201510:36 amRNSExercise of Employee Share Options
9th Mar 20157:00 amRNSAppointment to Executive Management Team
2nd Mar 201512:51 pmRNSEdison initiates coverage of Abzena Plc
26th Feb 20154:23 pmRNSDirector Dealings
9th Feb 20157:00 amRNSProduct Development Update
6th Feb 20152:51 pmRNSHuman Tissue Authority licence application
12th Jan 20157:00 amRNSCollaboration
22nd Dec 20144:57 pmRNSDirector Dealings
12th Dec 20143:50 pmRNSDirector Dealings
11th Dec 20147:00 amRNSInterim Results
2nd Dec 20147:00 amRNSNotice of Results
21st Aug 20144:29 pmRNSResearch & Licence Agreement
4th Aug 20147:00 amRNSAbzena Completes Relocation
10th Jul 20148:02 amRNSFirst Day of Dealings on AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.